Skip to main content
. 2022 Mar 7;4:838466. doi: 10.3389/ftox.2022.838466

FIGURE 10.

FIGURE 10

Bioactivity Exposure Ratio of Caffeine for the oral (A) and dermal (B) exposure scenarios, comparing the IPP, CSP and Httr PoDs with maternal and foetal Cmax values.